← Leaderboards
Barry A Berkowitz
Bessor Pharma, Llc
$2,207,947
Attributed
$5,182,555
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2016–24$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$5,182,555 · 5
By mechanism
R44$3,985,629 · 2
R43$1,196,926 · 3
Top collaborators
- Gary V. Desir8 shared
- Harriet M Kluger3 shared
Others in their field
Top investigators on “Signal Transduction”
- Peter B. Gilbert · Fred Hutchinson Cancer Center$148,539,615
- David Heimbrook · Leidos Biomedical Research, Inc.$82,049,940
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$70,290,471
- Garret A Fitzgerald · University Of Pennsylvania$66,142,222
- Michael Barry Kastan · Duke University$64,512,357
- Randall J Bateman · Washington University$62,939,456
Research focus
Signal TransductionDosePharmaceutical PreparationsNovel TherapeuticsIn VivoAcuteRecombinantsProteinsPeptidesResponseEnzyme-Linked Immunosorbent AssayTherapeutic IndexInnovationToxic EffectDrug KineticsInflammatoryPlasmaHospitalizationHourIl6 GeneMouse ModelOnset Of IllnessCell SurvivalKidney
Grant awards (8)
New target and new therapy for severe Covid-19 and viral hyperinflammation damage: renalase and renalase agonists$296,931
R43 · FY2024 · AI · contact PI
New target and new therapy for severe Covid-19 and viral hyperinflammation damage: renalase and renalase agonists$299,999
R43 · FY2023 · AI · contact PI
Novel Target, New Therapy: Anti- Renalase Antibody for Tumors Resistant to PD-1Inhibitors$672,231
R44 · FY2022 · CA · contact PI
Novel Target, New Therapy: Anti- Renalase Antibody for Tumors Resistant to PD-1Inhibitors$1,327,758
R44 · FY2021 · CA · contact PI
Renalase: Development as an Innovative New Drug for Acute Pancreatitis$1,136,337
R44 · FY2020 · DK · contact PI
Renalase: Development as an Innovative New Drug for Acute Pancreatitis$849,303
R44 · FY2019 · DK · contact PI
Humanized Anti-Renalase Antibodies for Unresectable Melanoma$299,996
R43 · FY2018 · CA · contact PI
Acute Pancreatitis: Renalase as a novel target and agonists as new therapy$300,000
R43 · FY2016 · DK · contact PI